Recombinant Mouse TRANCE/RANK L/TNFSF11 (E. coli-expressed)

  (26 citations)
(2 Reviews)
    
Datasheet / CoA / SDS
Product Details
Citations (26)
FAQs
Reviews
  • Purity
    >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
  • Endotoxin Level
    <0.01 EU per 1 μg of the protein by the LAL method.
  • Activity
    Measured by its ability to induce osteoclast differentiation of RAW 264.7 mouse monocyte/macrophage cells. The ED50 for this effect is 0.5‑2 ng/mL.
  • Source
    E. coli-derived mouse TRANCE/TNFSF11/RANK L protein
    Lys158-Asp316, with an N-terminal Met
  • Accession #
  • N-terminal Sequence
    Analysis
    Met
  • Predicted Molecular Mass
    19 kDa
Product Datasheets

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Certificate of Analysis Lookup

Certificate of Analysis Request Form

To download a Certificate of Analysis, please enter the catalog and lot numbers in the search box below.

Note: Certificate of Analysis not available for kit components.

Carrier Free
What does CF mean?
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
What formulation is right for me?
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
462-TEC
 
462-TEC/CF
Formulation Lyophilized from a 0.2 μm filtered solution in NaH2PO4, NaCl and EDTA with BSA as a carrier protein.
 
Formulation Lyophilized from a 0.2 μm filtered solution in NaH2PO4, NaCl and EDTA.
Reconstitution Reconstitute at 10 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
 
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
 
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
 
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Data Images
Recombinant Mouse TRANCE/TNFSF11/RANK L (Catalog # 462-TEC) induces osteoclast differentiation of the RAW 264.7 mouse monocyte/macrophage cell line. The ED50 for this effect is 0.5-2 ng/mL.
1 μg/lane of Recombinant Mouse TRANCE/TNFSF11/RANK L was resolved with SDS-PAGE under reducing (R) conditions and visualized by silver staining, showing a single band at 19 kDa.
Background: TRANCE/TNFSF11/RANK L

TRANCE (receptor activator of NF-kappa B ligand [RANK L], also called TNF-related activation-induced cytokine [TRANCE], osteoprotegrin ligand [OPGL], and osteoclast differentiation factor [ODF]), is a member of the tumor necrosis factor (TNF) family. TRANCE was originally identified as an immediate early gene up-regulated by T cell receptor stimulation. The mouse TRANCE cDNA encodes a type II transmembrane protein of 316 amino acids with a predicted cytoplasmic domain of 48 amino acids and an extracellular domain of 247 amino acids. The extracellular domain contains two potential N-linked glycosylation sites. Mouse and human TRANCE share 85% amino acid identity. TRANCE is primarily expressed in T cells and T cell rich organs, such as thymus and lymph nodes. The multi-functions of TRANCE include induction of activation of the c-jun N-terminal kinase, enhancement of T cell growth and dendritic cell function, induction of osteoclastogenesis, and lymph node organogenesis. RANK is the cell surface signaling receptor of TRANCE. RANK has been shown to undergo receptor clustering during signal transduction. Osteoprotegrin, a soluble member of the TNF receptor family which binds TRANCE, is a naturally occurring decoy receptor that counterbalances the effects of TRANCE.

  • References:
    1. Wong, B.R. et al. (1997) J. Biol. Chem. 272:25190.
    2. Anderson, D.M. et al. (1997) Nature 390:175.
    3. Nakagawa, N. et al. (1998) Biochem. Biophys. Res. Commun. 245:382.
    4. Kong, Y-Y. et al. (1999) Nature 397:315.
  • Long Name:
    TNF-related Activation-induced Cytokine
  • Entrez Gene IDs:
    8600 (Human); 21943 (Mouse); 117516 (Rat)
  • Alternate Names:
    CD254 antigen; CD254; ODF; OPGL; OPGLOPTB2; Osteoclast differentiation factor; Osteoprotegerin ligand; RANK L; RANKL; RANKLreceptor activator of nuclear factor kappa B ligand; Receptor activator of nuclear factor kappa-B ligand; sOdf; TNF-related activation-induced cytokine; TNFSF11; TRANCE; TRANCEODFhRANKL2; tumor necrosis factor (ligand) superfamily, member 11; tumor necrosis factor ligand superfamily member 11
Related Research Areas
Citations:

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

26 Citations: Showing 1 - 10
Filter your results:

Species
Applications
Sample Type
  1. Microbiota Reconstitution Does Not Cause Bone Loss in Germ-Free Mice
    Authors: D Quach, F Collins, N Parameswar, L McCabe, RA Britton
    mSphere, 2018;3(1):.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  2. The Effects of Kaempferol-Inhibited Autophagy on Osteoclast Formation
    Authors: CJ Kim, SH Shin, BJ Kim, CH Kim, JH Kim, HM Kang, BS Park, IR Kim
    Int J Mol Sci, 2018;19(1):.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  3. Effects of Osteogenic-Conditioned Medium from Human Periosteum-Derived Cells on Osteoclast Differentiation
    Authors: HC Park, YB Son, SL Lee, GJ Rho, YH Kang, BW Park, SH Byun, SC Hwang, IA Cho, YC Cho, IY Sung, DK Woo, JH Byun
    Int J Med Sci, 2017;14(13):1389-1401.
    Species: Human
    Sample Type: Cell Culture Supernates
  4. Small leucine rich proteoglycans, a novel link to osteoclastogenesis
    Authors: V Kram, TM Kilts, N Bhattachar, L Li, MF Young
    Sci Rep, 2017;7(1):12627.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  5. SNX10 gene mutation leading to osteopetrosis with dysfunctional osteoclasts
    Authors: EL Stattin, P Henning, J Klar, E McDermott, C Stecksen-B, PE Sandström, TG Kellgren, P Rydén, G Hallmans, T Lönnerholm, A Ameur, MH Helfrich, FP Coxon, N Dahl, J Wikström, UH Lerner
    Sci Rep, 2017;7(1):3012.
    Species: Human
    Sample Type: Whole Cells
    Application: Bioassay
  6. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors
    Authors: F Strålberg, A Kassem, F Kasprzykow, M Abrahamson, A Grubb, C Lindholm, UH Lerner
    J. Leukoc. Biol, 2017;0(0):.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  7. Dynamics of the sealing zone in cultured osteoclasts
    Authors: Sarit Batsir
    Cytoskeleton (Hoboken), 2016;0(0):.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  8. Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice
    Authors: Erivan S Ramos-Juni
    J. Bone Miner. Res, 2016;0(0):.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  9. Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome.
    Authors: Khor E, Fanshawe B, Qi Y, Zolotukhin S, Kulkarni R, Enriquez R, Purtell L, Lee N, Wee N, Croucher P, Campbell L, Herzog H, Baldock P
    PLoS ONE, 2016;11(1):e0148155.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  10. Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation
    PLoS ONE, 2016;11(11):e0166284.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  11. Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures.
    Authors: Fowler T, Kamalakar A, Akel N, Kurten R, Suva L, Gaddy D
    J Cell Sci, 2015;128(4):683-94.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  12. Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiation.
    Authors: Mediero A, Ramkhelawon B, Perez-Aso M, Moore K, Cronstein B
    J Bone Miner Res, 2015;30(5):837-54.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  13. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/beta-CATENIN SIGNALING PATHWAY.
    Authors: Beier E, Sheu T, Dang D, Holz J, Ubayawardena R, Babij P, Puzas J
    J Biol Chem, 2015;290(29):18216-26.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  14. A nonapoptotic role for CASP2/caspase 2: modulation of autophagy.
    Authors: Tiwari, Meenaksh, Sharma, Lokendra, Vanegas, Difernan, Callaway, Danielle, Bai, Yidong, Lechleiter, James D, Herman, Brian
    Autophagy, 2014;10(6):1054-70.
  15. TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation.
    Authors: Sun Q, Sammut B, Wang F, Kurihara N, Windle J, Roodman G, Galson D
    J Bone Miner Res, 2014;29(1):90-102.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  16. Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model.
    Authors: Schwarzer R, Nickel N, Godau J, Willie B, Duda G, Schwarzer R, Cirovic B, Leutz A, Manz R, Bogen B, Dorken B, Jundt F
    Blood Cancer J, 2014;4(0):e217.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  17. NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-kappaB.
    Authors: Zhang H, Hilton M, Anolik J, Welle S, Zhao C, Yao Z, Li X, Wang Z, Boyce B, Xing L
    J Clin Invest, 2014;124(7):3200-14.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  18. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation.
    Authors: Xiu Y, Xu H, Zhao C, Li J, Morita Y, Yao Z, Xing L, Boyce B
    J Clin Invest, 2014;124(1):297-310.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  19. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis.
    Authors: Muruganandan S, Dranse H, Rourke J, McMullen N, Sinal C
    Stem Cells, 2013;31(10):2172-82.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  20. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.
    Authors: Stalvey M, Clines K, Havasi V, McKibbin C, Dunn L, Chung W, Clines G
    PLoS ONE, 2013;8(11):e80098.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  21. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.
    Authors: Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, Yamada H, Okada S, Watari K, Ono M, Kuwano M, Kamura S, Iida K, Okada Y, Koga M, Iwamoto Y
    Am. J. Pathol., 2011;179(3):1157-70.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  22. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE.
    Authors: Kulkarni RN, Bakker AD, Everts V, Klein-Nulend J
    Calcif. Tissue Int., 2010;87(5):461-8.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  23. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis.
    Authors: Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig TM, Mack M, Erben RG, Smolen JS, Redlich K
    Nat. Med., 2009;15(4):417-24.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  24. Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice.
    Authors: Johansson MK, de Vries TJ, Schoenmaker T, Ehinger M, Brun AC, Fasth A, Karlsson S, Everts V, Richter J
    Blood, 2007;109(12):5178-85.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  25. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts.
    Authors: de Vries TJ, Schoenmaker T, Wattanaroonwong N, van den Hoonaard M, Nieuwenhuijse A, Beertsen W, Everts V
    J. Cell. Biochem., 2006;98(2):370-82.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  26. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.
    Authors: Liao TS, Yurgelun MB, Chang SS, Zhang HZ, Murakami K, Blaine TA, Parisien MV, Kim W, Winchester RJ, Lee FY
    J. Orthop. Res., 2005;23(1):203-9.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
Expand to show all Citations

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs
Average Rating: 5 (Based on 2 reviews)

Have you used Recombinant Mouse TRANCE/RANK L/TNFSF11 (E. coli-expressed)?

Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Read what people are saying who have used Recombinant Mouse TRANCE/RANK L/TNFSF11 (E. coli-expressed).

We have 2 reviews tested in 2 applications: Media additive for protein or antibody production, Stem/Immune cell maintenance or differentiation .

Filter by Ratings
Excellent
(2)
All Ratings
Filter by Applications
Media additive for protein or antibody production
(1)
Stem/Immune cell maintenance or differentiation
(1)
All Applications
Filter by Species
All Species

Images Ratings Applications Species Reviewed By Date Details
  Excellent
 Media additive for protein or antibody production Anonymous 05/16/2016
Show

Summary

Application Media additive for protein or antibody production
  Excellent
 Stem/Immune cell maintenance or differentiation Anonymous 01/18/2016
Show

Summary

Application Stem/Immune cell maintenance or differentiation

Please scroll the above reviews for more

Order Details

  • Formulations
Contact Us to Order
reload

Feedback

Customer Information
Calculators

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷
R&D Systems Guarantee